Neurodegenerative Disorders: Spotlight on Sphingolipids

Neurodegenerative diseases are incurable diseases of the nervous system that lead to a progressive loss of brain areas and neuronal subtypes, which is associated with an increase in symptoms that can be linked to the affected brain areas. The key findings that appear in many neurodegenerative diseas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Frida Mandik, Melissa Vos
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2078e579278f4cdf9cd4516936b2f8e2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2078e579278f4cdf9cd4516936b2f8e2
record_format dspace
spelling oai:doaj.org-article:2078e579278f4cdf9cd4516936b2f8e22021-11-11T17:24:44ZNeurodegenerative Disorders: Spotlight on Sphingolipids10.3390/ijms2221119981422-00671661-6596https://doaj.org/article/2078e579278f4cdf9cd4516936b2f8e22021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11998https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Neurodegenerative diseases are incurable diseases of the nervous system that lead to a progressive loss of brain areas and neuronal subtypes, which is associated with an increase in symptoms that can be linked to the affected brain areas. The key findings that appear in many neurodegenerative diseases are deposits of proteins and the damage of mitochondria, which mainly affect energy production and mitophagy. Several causative gene mutations have been identified in various neurodegenerative diseases; however, a large proportion are considered sporadic. In the last decade, studies linking lipids, and in particular sphingolipids, to neurodegenerative diseases have shown the importance of these sphingolipids in the underlying pathogenesis. Sphingolipids are bioactive lipids consisting of a sphingoid base linked to a fatty acid and a hydrophilic head group. They are involved in various cellular processes, such as cell growth, apoptosis, and autophagy, and are an essential component of the brain. In this review, we will cover key findings that demonstrate the relevance of sphingolipids in neurodegenerative diseases and will focus on neurodegeneration with brain iron accumulation and Parkinson’s disease.Frida MandikMelissa VosMDPI AGarticlesphingolipidsceramideneurodegenerationNBIAParkinson’s diseaseBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11998, p 11998 (2021)
institution DOAJ
collection DOAJ
language EN
topic sphingolipids
ceramide
neurodegeneration
NBIA
Parkinson’s disease
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle sphingolipids
ceramide
neurodegeneration
NBIA
Parkinson’s disease
Biology (General)
QH301-705.5
Chemistry
QD1-999
Frida Mandik
Melissa Vos
Neurodegenerative Disorders: Spotlight on Sphingolipids
description Neurodegenerative diseases are incurable diseases of the nervous system that lead to a progressive loss of brain areas and neuronal subtypes, which is associated with an increase in symptoms that can be linked to the affected brain areas. The key findings that appear in many neurodegenerative diseases are deposits of proteins and the damage of mitochondria, which mainly affect energy production and mitophagy. Several causative gene mutations have been identified in various neurodegenerative diseases; however, a large proportion are considered sporadic. In the last decade, studies linking lipids, and in particular sphingolipids, to neurodegenerative diseases have shown the importance of these sphingolipids in the underlying pathogenesis. Sphingolipids are bioactive lipids consisting of a sphingoid base linked to a fatty acid and a hydrophilic head group. They are involved in various cellular processes, such as cell growth, apoptosis, and autophagy, and are an essential component of the brain. In this review, we will cover key findings that demonstrate the relevance of sphingolipids in neurodegenerative diseases and will focus on neurodegeneration with brain iron accumulation and Parkinson’s disease.
format article
author Frida Mandik
Melissa Vos
author_facet Frida Mandik
Melissa Vos
author_sort Frida Mandik
title Neurodegenerative Disorders: Spotlight on Sphingolipids
title_short Neurodegenerative Disorders: Spotlight on Sphingolipids
title_full Neurodegenerative Disorders: Spotlight on Sphingolipids
title_fullStr Neurodegenerative Disorders: Spotlight on Sphingolipids
title_full_unstemmed Neurodegenerative Disorders: Spotlight on Sphingolipids
title_sort neurodegenerative disorders: spotlight on sphingolipids
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2078e579278f4cdf9cd4516936b2f8e2
work_keys_str_mv AT fridamandik neurodegenerativedisordersspotlightonsphingolipids
AT melissavos neurodegenerativedisordersspotlightonsphingolipids
_version_ 1718432104381939712